New settlement proposed in First DataBank AWP suit
A new settlement has been proposed in the average wholesale price suit against First DataBank, McKesson, and Medi-Span.
Ohio Board of Pharmacy investigates Cardinal distribution center
The Ohio Board of Pharmacy is investigating the Cardinal distribution center in Findlay, Ohio, for distributing large amounts of controlled substances to an Internet pharmacy.
R.I. jury acquits two former CVS executives of corruption charges
Two former CVS executives have been acquitted of bribing a Rhode Island state senator for legislative favors.
Three Florida doctors and six others charged in $56 million healthcare fraud
Three Miami area doctors and six others were charged for defrauding Medicare.
Illegal Internet pharmacy caught by long arm of the law
A California man faces incarceration and a hefty fine for selling drugs over the Internet without the proper safeguards in place.
Part D claims data to be grist for research mill under new CMS rule
CMS issues a final rule letting researchers and HHS access Part D claims data for research purposes.
FDA requests recall of Xiadafil VIP Tabs
SEI Pharmaceuticals' Xiadafil VIP Tabs are being recalled for containing a substance that could hurt patients.
Express Scripts to pay more than $9 million to settle drug switching charges
Express Scripts has agreed to pay 28 states and the District of Columbia $9.3 million to settle charges that it switched cholesterol-lowering drugs for financial gain.
CMS asks for extension before issuing final rule on hospices
CMS will need more time before it issues a final rule on conditions for hospices to participate in Medicare and Medicaid.
FDA warns that nipple cream can hurt nursing babies
FDA warns about the dangers in Mommy's Bliss Nipple Cream.
San Francisco sues McKesson over AWP
The City of San Francisco is suing McKesson in federal court, alleging that the wholesaler conspired to inflate the gap between wholesale acquisition costs and average wholesale prices.
New study gives insights into overall satisfaction with Medicare Part D
The results of 13 focus groups on Medicare Part D have been compiled into a report for MedPAC.
FDA to pharmacies: Don't dispense Scientific Laboratories products
Because Scientific Laboratories' products are not approved or have not met good manufacturing practices, FDA is barring them from being sold.
Consumers Union urges FDA to require TV ads include toll free number
Consumers Union is urging the FDA to move ahead with requiring TV ads for Rx drugs to include a toll free number and a Web site address to report serious side effects from presciption drugs.
How drug plans can survive their Part D audit
An expert gives drug plans advice on how to pass a Medicare Part D audit
Stolen drugs are being withdrawn as a precaution
Several lots of Doxil, Procrit, and Remicade have been stolen, prompting the manufacturers to issue a voluntary withdrawal of the lots affected.
Pennsylvania passes law letting unused cancer drugs to be returned
A new Pennsylvania law sets up a voluntary drug repository program for cancer patients.
FDA to launch pilot on drug names and safety
FDA is holding a meeting, launching a pilot, and releasing a concept paper about drug names next month.
Oklahoma pharmacies can now renew their narcotic registration online
Oklahoma pharmacies can now renew their narcotic registration electronically.
Medicare is revising how it pays hospitals and private insurers are following closely behind
The Centers for Medicare & Medicaid Services has added new critiera hospitals must meet in order to get optimal reimbursement
Academic detailing gathers momentum
Congress is considering legislation to establish an academic detailing program to cut healthcare costs
California board delays e-pedigree rule until 2011
The California board of pharmacy has decided to postpone its electronic pedigree rule that was expected to go into effectin January 2009
Legal Q & A: Can R.Ph.s fill self-prescribed Rxs or Rxs for family members?
States vary in their laws regarding whether pharmacists can dispense when they receive a prescription ordered by the physician for himself or his family members
FDA's Ilisa Bernstein discusses current state of pharmacy affairs
Ilisa Bernsteain, FDA's director of pharmacy affairs talks to Drug Topics about a variety of pharmacy issues, including e-pedigree, REMS plans, risk management plans and other issus.
Employers and pharmacists team up to drive down healthcare costs
Employers look to pharmacists to improve employees' chronic care to reduce healthcare costs and improve health.
Lawsuit aims to stop Medi-Cal cuts
The largest California independent living center, two pharmacies, and two Medi-Cal recipients sued Medi-Cal to set aside plans to cut reimbursement
Vaccines and inhaled insulin in, erectile dysfunction drugs out of Part D
The Centers for Medicare & Medicaid Services issues a final rule clarifying its position on the inclusion of insulin and exclusion of erectile dysfunction medications in the Medicare Part D program.
NCPA, NACDS amend AMP suit to include new CMS rule
NCPA and the NACDS have amended their average manufacturer price lawsuit to include CMS' interim final rule on multiple-source drugs
Medtronic recalling devices coated with heparin
Medical devices featuring the Carmeda BioActive surface from Medtronic are being recalled because they are made with the contaminated heparin made in China.
